A detailed history of Janney Montgomery Scott LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 7,199 shares of AXSM stock, worth $716,228. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,199
Previous 5,630 27.87%
Holding current value
$716,228
Previous $453,000 42.83%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$78.93 - $95.84 $123,841 - $150,372
1,569 Added 27.87%
7,199 $647,000
Q2 2024

Jul 25, 2024

SELL
$65.72 - $80.5 $9,858 - $12,075
-150 Reduced 2.6%
5,630 $453,000
Q1 2024

May 01, 2024

BUY
$69.39 - $97.64 $34,695 - $48,820
500 Added 9.47%
5,780 $461,000
Q4 2023

Feb 07, 2024

SELL
$57.42 - $83.61 $16,077 - $23,410
-280 Reduced 5.04%
5,280 $420,000
Q3 2023

Nov 08, 2023

BUY
$69.25 - $82.21 $74,305 - $88,211
1,073 Added 23.91%
5,560 $389,000
Q2 2023

Jul 26, 2023

BUY
$58.41 - $90.35 $262,085 - $405,400
4,487 New
4,487 $322,000
Q4 2022

Feb 01, 2023

BUY
$39.94 - $79.72 $112,031 - $223,614
2,805 New
2,805 $216,000
Q2 2022

Aug 03, 2022

SELL
$21.74 - $46.75 $124,396 - $267,503
-5,722 Closed
0 $0
Q1 2022

May 04, 2022

SELL
$23.7 - $41.39 $7,749 - $13,534
-327 Reduced 5.41%
5,722 $237,000
Q4 2021

Jan 27, 2022

BUY
$30.7 - $43.36 $185,704 - $262,284
6,049 New
6,049 $229,000
Q3 2021

Oct 29, 2021

SELL
$19.91 - $68.26 $209,851 - $719,460
-10,540 Closed
0 $0
Q2 2021

Jul 26, 2021

BUY
$50.63 - $73.5 $25,315 - $36,750
500 Added 4.98%
10,540 $711,000
Q1 2021

Apr 27, 2021

BUY
$55.91 - $81.44 $4,752 - $6,922
85 Added 0.85%
10,040 $568,000
Q4 2020

Jan 25, 2021

BUY
$66.31 - $86.52 $20,688 - $26,994
312 Added 3.24%
9,955 $811,000
Q3 2020

Nov 06, 2020

SELL
$68.34 - $85.84 $77,155 - $96,913
-1,129 Reduced 10.48%
9,643 $687,000
Q2 2020

Jul 23, 2020

BUY
$49.87 - $98.69 $120,485 - $238,435
2,416 Added 28.91%
10,772 $886,000
Q1 2020

Apr 30, 2020

SELL
$41.2 - $101.31 $576,964 - $1.42 Million
-14,004 Reduced 62.63%
8,356 $492,000
Q4 2019

Jan 21, 2020

SELL
$16.71 - $106.24 $102,181 - $649,657
-6,115 Reduced 21.47%
22,360 $2.31 Million
Q3 2019

Oct 29, 2019

BUY
$20.24 - $29.16 $19,228 - $27,702
950 Added 3.45%
28,475 $576,000
Q2 2019

Jul 29, 2019

BUY
$13.46 - $25.75 $133,927 - $256,212
9,950 Added 56.61%
27,525 $709,000
Q1 2019

Apr 30, 2019

BUY
$2.63 - $16.34 $46,222 - $287,175
17,575 New
17,575 $250,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $4.27B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.